TY - CONF A1 - Piedada, F. M. A1 - Simöes, R. G. A1 - Bernardes, C.E.S. A1 - Joseph, A. A1 - Kraus, Werner A1 - Diogo, H. A1 - Emmerling, Franziska A1 - da Piedada, M. E. M. T1 - Polymorphism in Simvastatin: A Single Crystal X-ray Diffraction, Themodynamic, and MDSimulation Study N2 - Simvastatin is a prominent member of the statin family, a class of antilipidemic drugs widely used in the treatment of high plasma cholesterol levels, and thus in the prevention of atherosclerosis and cardiovascular diseases. Simvastatin is typically employed as a solid and it is well known that, in this case, the detection and characterization of polymorphism is of considerable importance. Polymorphs differ by their packing arrangements and also, occasionally, by the conformations of the molecules in the crystal lattice. These structural variations are normally reflected by differences in physical properties, such as solubility and dissolution rate in a given media, which may significantly affect the bioavailability of a drug. The lack of control of polymorphism can, therefore, play havoc with the safe use of a drug. T2 - COST Action CM1402 CY - Lincoln, United Kingdom DA - 26.06.2017 KW - Polymorphism KW - X-ry Diffraction PY - 2017 AN - OPUS4-41252 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -